SCHEMBL29872986

SCHEMBL29872986

COc1ccc(Cn2nc(OC(F)F)c3cc(O)cnc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.45
▸ CNR1 P21554 1/20 0.45
▸ PDE5A O76074 1/20 0.40
▸ PDE1B Q01064 9/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ACVR1B P36896 1/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ ACVRL1 P37023 1/20 0.36
▸ ACVR1 Q04771 1/20 0.36
▸ MET P08581 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ BCHE P06276 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24566406 0.89 CNR1 (0.50) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL23069175 0.88 CNR1 (0.43) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29873478 0.88 CNR1 (0.43) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL23069164 0.87 PDE1B (0.50) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29872865 0.87 PDE1B (0.50) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29872618 0.83 CNR1 (0.39) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL23069193 0.81 CNR1 (0.44) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29873129 0.79 MAPT (0.46) CNR2CNR1PDE5ALMNAMAPT
SCHEMBL29872989 0.79 BUB1 (0.40) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29873410 0.77 PDE1B (0.43) CNR2CNR1PDE1BALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220306640-A1 HYDANTOIN DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2022-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220306640-A1 HYDANTOIN DERIVATIVE DDR1, DDR2, DDRGK1 CNR2 3824/4885CNR1 2761/4885PDE5A 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback